Abstract

Lipids released from circulating lipoproteins by intravascular action of lipoprotein lipase (LpL) reach parenchymal cells in tissues with a non-fenestrated endothelium by transfer through or around endothelial cells. The actions of LpL are controlled at multiple sites, its synthesis and release by myocytes and adipocytes, its transit and association with the endothelial cell luminal surface, and finally its activation and inhibition by a number of proteins and by its product non-esterified fatty acids. Multiple pathways mediate endothelial transit of lipids into muscle and adipose tissues. These include movement of fatty acids via the endothelial cell fatty acid transporter CD36 and movement of whole or partially LpL-hydrolyzed lipoproteins via other apical endothelial cell receptors such as SR-B1and Alk1. Lipids also likely change the barrier function of the endothelium and operation of the paracellular pathway around endothelial cells. This review summarizes in vitro and in vivo support for the key role of endothelial cells in delivery of lipids and highlights incompletely understood processes that are the focus of active investigation.

Original languageEnglish
Pages (from-to)1-8
Number of pages8
JournalAtherosclerosis
Volume329
DOIs
StatePublished - Jul 2021

Keywords

  • CD36
  • Fatty acids
  • Lipoprotein lipase
  • Scavenger receptors
  • Triglyceride

Fingerprint

Dive into the research topics of 'Lipolytic enzymes and free fatty acids at the endothelial interface'. Together they form a unique fingerprint.

Cite this